CD8A and central nervous system cancer: As shown in Fig. 4c (Supplementary Fig. 7), we evaluated the ability of Chek2 depleted glioma cells to present MHCI restricted OVA peptide-SIINFEKL and activate SIINFEKL-specific OT-I CD8+ T cells.